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ABSTRACT
Objective: To investigate endotoxins in sterilized surgical instruments used in hip 
arthroplasties. Method: A descriptive exploratory study conducted in a public teaching 
hospital. Six types of surgical instruments were selected, namely: acetabulum rasp, 
femoral rasp, femoral head remover, chisel box, flexible bone reamer and femoral head 
test. The selection was based on the analysis of the difficulty in removing bone and blood 
residues during cleaning. The sample was made up of 60 surgical instruments, which were 
tested for endotoxins in three different stages. The EndosafeTM Gel-Clot LAL (Limulus 
Amebocyte Lysate method) was used. Result: There was consistent gel formation with 
positive analysis in eight instruments, corresponding to 13.3%, being four femoral 
rasps and four bone reamers. Conclusion: Endotoxins in quantity ≥0.125 UE/mL were 
detected in 13.3% of the instruments tested.
DESCRIPTORS
Endotoxins; Surgical Instruments; Arthroplasty, Replacement, Hip; Orthopedic Nursing; 
Operating Room Nursing.
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INTRODUCTION
Joint replacement surgeries using orthopedic implants 
bring benefits to patients, such as pain relief and recovery 
of movements. However, they require long-term follow-up 
to determine their effectiveness and safety, since they might 
involve complications(1-2).
There are two flaws associated with orthopedic implants. 
The first is of mechanical nature, resulting from the exces-
sive use of the prosthesis, its displacement or misalignment, 
physical stress and bone fracture. The second is of biologi-
cal nature, caused by inflammation due to the presence of 
particles where the prosthesis is located. Although infection 
is one of the causes for the loosening of a prosthesis in 
about 1.5% of the patients, a non-infectious complication or 
aseptic loosening is the main cause of surgical revision(3-5).
In the United States, 500,000 arthroplasties are per-
formed every year; of these, 40,000 undergo through revi-
sions due to aseptic loosening, often associated with the 
presence of endotoxins. Presence of osteolysis around the 
prosthesis is observed in aseptic loosening, due to the pres-
ence of particles generated from the implant. If endotoxins 
are present, they adhere to these particles, being probably 
one more factor to inducing the loosening. Endotoxins are 
found in the outermost membrane of Gram-negative bacte-
ria and belong to the phospholipids class called lipopolysac-
charides (LPS). Their release occurs due to the cell death, 
but there is evidence that it happens in a lower proportion, 
during the process of cell growth and division(3-7).
These findings suggest the need to know the endotox-
ins’ role in these situations of inflammatory response, where 
there are not clinical and microbiological signs of infec-
tion. Initially, it might seem contradictory to address aseptic 
loosening without excluding the presence of a subclinical 
level of bacteria that may colonize orthopedic implants, 
form biofilm and be the source of endotoxins(5).
The limit of endotoxins in health devices was regu-
lated by the U.S. Food and Drug Administration (FDA) 
for manufacturers of medical devices, and it depends on 
both the intended use and their contact with body surfaces, 
spaces and fluids. For devices that come into direct or indi-
rect contact with cardiovascular and lymphatic systems, the 
limit is 0.5 UE/mL or 20 UE/device. However, regarding 
devices that come into contact with the cerebrospinal fluid, 
the limit is 0.06 UE/mL or 2.15 UE/device. Nonetheless, 
there are not established or regulated limits for endotox-
ins in sterilized surgical instruments, or any requirement to 
conduct tests that evaluate their presence(7-9).
In this respect, the hypothesis that there might be en-
dotoxins in surgical instruments is presented and, therefore, 
they can contribute to the aseptic loosening of orthopedic 
implants. Therefore, the objective of this study was to in-
vestigate the presence of endotoxins in sterilized surgical 
instruments used in hip arthroplasties.
METHOD
A descriptive exploratory study was conducted to inves-
tigate endotoxins in sterilized surgical instruments used in 
hip arthroplasty surgeries.
The study was conducted in a public teaching hospital 
that provides high complexity care in traumatology, located 
in the city of Belo Horizonte, in the state of Minas Gerais. 
This hospital has a surgical center with six operating rooms 
and a sterile processing department (SPD), where surgical 
instruments are processed.
Specific sets of surgical instruments for hip arthroplasty 
contain about 50 pieces (Figure 1). These were analyzed 
along with the nurse coordinator of the SPD and the or-
thopedic physician coordinator of hip surgery, with the aim 
to classify instruments that present difficulty in the removal 
of bone and blood residues during the cleaning for further 
sterilization. Six types of surgical instruments were selected, 
namely: acetabulum rasp, femoral rasp, femoral head re-
mover, chisel box, flexible bone reamer and femoral head 
test, totaling 29 pieces.
Source: author’s file.
Figure 1 – Set of surgical instruments for hip arthroplasty – Belo 
Horizonte, Minas Gerais, Brazil, 2014.
The instruments’ sample size was calculated considering 
studies with the aim to define if a specific event occurs or 
not in a given population(10). More specifically, to identify 
the presence of endotoxins in the selected instruments used 
in hip arthroplasties. In this situation, the calculation of the 
sample size (n) follows:
log(1− p)
n =
log(   )β
where: 1 – b = power of the study (usually b = 0.05 or b = 0.10)
p = expected proportion of the event’s occurrence in the population
In the sample calculation, an expected proportion (p) of at 
least 10% of presence of endotoxin in instruments (p = 0.10) 
and a power of 90% (b = 0.10) were considered. In this case, 
the sample size must include at least 22 instruments.
The selected instruments were submitted to the SPD 
routine processes, namely: cleaning with enzymatic deter-
gent in ultrasonic and manual washers; rinsing in drinking 
water; packaging in polypropylene blanket and sterilization 
in saturated steam under pressure. The SPD made the surgi-
cal instruments available in three different stages, in which 
25, 17 and 18 pieces were respectively tested, totaling 60 
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instruments. It is important to note that the tests were con-
ducted according to the material provided by the hospital, 
considering that it was not possible to test the 29 selected 
pieces initially, in none of the three stages.
In the SPD daily routine, the sterilization processes are 
monitored by physical, chemical and biological indicators. 
The unit uses drinking water for the processing of materi-
als, whose standards are evaluated every four months, ac-
cording to the edict MS No. 2914/2011(11) of the Brazilian 
Ministry of Health. The validation of the steam sterilization 
process in the SPD is conducted every year for sterilization 
assurance, which includes the qualification of equipment 
regarding their installation, operation and performance. 
Laboratorial analyses were conducted in the microbiology 
department of the Instituto de Ciências Biológicas of the 
Universidade Federal de Minas Gerais (ICB/UFMG, as per 
its acronym in Portuguese).
The sterilized surgical instruments ready for use were 
analyzed with the EndosafeTM gel-clot LAL method 
(Limulus Amebocyte Lysate by Charles River Laboratories, 
Inc. USA) for the detection of endotoxins, according to 
standards established by the US Pharmacopoeia(12).
Using the aseptic technique in laminar flow cabinet, 
the instruments were transferred to a sterile container with 
200mL of water for apyrogenic injection (AI). They were 
submitted to sonication through the Bransonic 2510R-MT 
Ultrasonic Cleaner for 30 seconds, at a frequency of 42KHz 
and vortex agitation for 15 seconds. After this process, an 
aliquot of 20mL of AI obtained from the processing of each 
instrument was transferred to an apyrogenic conical tube, 
for conducting the endotoxins detection test.
The biological principle of the EndosafeTM LAL test de-
rives from the blood coagulation observed in the American 
horseshoe crab Limitus polyphemus, when in contact with 
lipopolysaccharides (LPS) present in Gram-negative bac-
teria. The test used presents lambda (λ) sensitivity of 0.125 
UE/mL, which corresponds to 0.025 ng/mL.
The Endosafe™ LAL and the standard endotoxin were 
reconstituted with AI, according to the manufacturer’s 
guidelines. After the reconstitution of the endotoxin, series 
of dilutions were conducted to confirm the LAL sensitivity. 
The test tubes were prepared in duplicate with 100µL of the 
diluted solutions and for the positive controls, according to 
the manufacturer’s indication. Then, 100µL of LAL reagent 
were added. The same procedure was conducted for the ex-
periment tubes, being 100µL of the conical tubes trans-
ferred to the test tubes in duplicate, and 100µL of LAL 
reagent were added.
The test tubes were incubated in water-bath for one 
hour, at the temperature of 37 ± 1°C. The reading of each 
tube was conducted according to the manufacturer’s in-
structions, that is, by direct observation of gel formation, 
being the result interpreted as positive when the tube is 
inverted to 180o and the gel maintains its integrity. The 
negative result is characterized by the absence of gel or a 
viscous mass that does not adhere to the bottom of the tube 
when it is inverted. All glassware used in the experiments 
was previously depyrogenazed through a method previously 
validated by the manufacturer.
For statistical analysis, the proportion of contamination 
from endotoxin was estimated by means of point estimation 
and by 95% confidence interval.
The research project was approved by the Research Ethics 
Committee of the Universidade Federal de Minas Gerais – 
UFMG, under protocol no ETIC 0300.0.203.000-10.
RESULTS
The surgical instruments submitted to analysis for the 
detection of endotoxins totaled 60 pieces and are presented 
in Table 1.
Table 1 – Distribution of complex surgical instruments obtained 
for test: risk of contamination from endotoxins – Belo Horizonte, 










interval for risk of 
endotoxins
Acetabulum 
rasp 19 0 — —
Femoral rasp 15 4 27% [5%; 49%]
Femoral head 
remover 1 0 — —
Chisel box 1 0 — —
Initial reamer 2 0 — —
Femoral 
head test 12 0 — —
Acetabulum 
test 5 0 — —
Flexible bone 
reamer 5 4 80% [28%; 99%]
Total 60 8 13% [6%; 26%]
In the first stage, the hospital provided 25 sterilized 
surgical instruments for analysis, namely: eight acetabulum 
rasps, eight femoral rasps, one femoral head remover, one 
chisel box, one initial reamer and six femoral head tests. In 
the second stage, 17 instruments were provided, being eight 
acetabulum rasps, four femoral rasps and five acetabulum 
tests. In the third stage, 18 instruments were provided, be-
ing three acetabulum rasps, three femoral rasps, one initial 
reamer, six femoral head tests and five flexible bone reamers.
After tests were conducted in the first stage, consistent 
gel formation was observed, with positive analysis for endo-
toxins in four femoral rasps among the 25 surgical instru-
ments. Tests in the second stage did not show consistent 
gel formation in any of the 17 surgical instruments tested. 
Tests in the third stage showed consistent gel formation 
with positive analysis for endotoxins in four flexible bone 
reamers among the 18 surgical instruments.
The positive analysis represents a quantity of ≥0.125 UE/
mL in the solution of the instrument tested. Therefore, for 
60 instruments submitted to test for the detection of endo-
toxins, there was consistent gel formation with positive anal-
ysis in eight surgical instruments, corresponding to 13.3%.
DISCUSSION
The unit that processes surgical instruments in health 
services should meet minimum quality standards to ensure 
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patient safety(13). The conditions for processing surgical in-
struments practiced in 249 SPDs were investigated by the 
health department of England, classifying them by a quality 
standard. The evaluation had the aim to investigate provision 
and use of equipment, trained human resources, manage-
ment and technical support to the reprocessing and compli-
ance with good practice and current legislation. Furthermore, 
the units were evaluated regarding the adoption of special 
care for the processing of materials used in procedures with a 
high risk of transmitting the variant of the Creutzfeldt-Jacob 
disease. The results showed that 44% of the services were 
classified with unacceptable standards, and only 17% were 
classified with good standards. In this respect, the govern-
ment developed an action plan, announced investments to 
improve the SPDs and a new evaluation was conducted(14).
The presence of endotoxins in 80% of the flexible bone 
reamers reinforces the technical difficulty in processing this 
study, reported by professionals who work in SPDs. It is 
recommended that the solution used for the cleaning of in-
struments have contact with all their surfaces; furthermore, 
composite materials must have their parts dismantled, ac-
cording to the manufacturer’s guidelines. In case the clean-
ing of all surfaces cannot be performed, residues of organic 
matter may remain, and if they are not removed before ster-
ilization, they may cause harm to patients(15).
In Brazil, SPDs are regulated by the National Health 
Surveillance Agency (ANVISA, as per its acronym in 
Portuguese), which established good practice requirements 
for the processing of health products in 2012. Aspects 
such as human resources and materials, infrastructure and 
all processes performed in this area are regulated both for 
health services and reprocessing companies. Regarding the 
rinsing water for health products, it must meet drinkability 
standards; however, the rinsing of critical materials used in 
surgeries of orthopedic implants must be performed with 
purified water(16).
The Brazilian Pharmacopeia establishes standards and 
defines purified water as drinking water that was submit-
ted to any kind of treatment for the removal of potential 
contaminants, and the treatment process consists of dis-
tillation, ion exchange, and reverse osmosis. It must meet 
purity requirements and be tested regarding its acidity and 
alkalinity, oxidizable substances, conductivity, total organic 
carbon, ammonium, calcium and magnesium, chlorides, 
nitrates and sulfates; it must be tested for microbiologi-
cal safety by the counting of mesophilic microorganisms. 
Ultra-pure water is the purified water submitted to addi-
tional treatment, which is generally used in laboratory test 
procedures. The Brazilian Pharmacopeia does not establish 
a requirement for testing endotoxins in purified or ultra-
pure water(17). Therefore, the use of the American guide is 
necessary to define endotoxin standards in the water used 
for processing materials in the SPD(18). It is believed that 
only making use of the Brazilian regulation to structure the 
SPD does not ensure good practices associated with the 
purity or absence of endotoxins in water.
The endotoxins’ role in the aseptic loosening of im-
plants is still not clear; however, researchers proved that 
endotoxins are at least partially responsible. Their presence 
increases cellular response to particles generated from the 
implant, and they probably interact with particle loading, 
implant movement, mechanical strength and floating head 
pressure to induce the prosthesis loosening. Studies suggest 
that endotoxins adhered to an implant interfere in its os-
seointegration, causing its loosening(5-19).
In 2005, researchers defined three potential sources of 
endotoxins to patients with aseptic loosening of implants, 
namely: (1) before surgery, the implant may contain a sig-
nificant amount of endotoxin adhered to its surface; (2) cir-
culating endotoxin generated from gut microbiota, minor 
infections or dental procedures may accumulate in the par-
ticles generated from the use of the prosthesis or in the tis-
sue around the implant; (3) subclinical bacterial biofilm. The 
authors affirm that microbiological studies have showed the 
presence of bacteria in the implant surface of patients who 
presented aseptic loosening, despite the absence of clinical 
signs of infection(5-19).
Considering the possibility that the water used in the 
processing of surgical instruments might be infected by 
Gram-negative bacteria and might be the source of endo-
toxins(6), it is important to care about the structural condi-
tions in the SPDs, since they are units destined to the pro-
cessing of health products. The effective decontamination 
of surgical instruments is one of the main components of 
quality care to ensure patient safety(13).
Furthermore, surgical instruments processed by SPDs may 
become the fourth potential source of endotoxin and contrib-
ute to the loosening of orthopedic prostheses. It is important 
to consider the additional risk associated with the multiple 
use of orthopedic instruments that usually belong to the pros-
thesis supplier, instead of the health service. Consequently, 
the instruments are used by several health services, which is a 
factor that may contribute to the development and accumula-
tion of bacterial biofilm on their surfaces(20).
Considering the contamination of surgical instruments 
from endotoxins a complex matter, structural conditions 
that minimize their presence are necessary. Furthermore, the 
guide of the Association for the Advancement of Medical 
Instrumentation (AAMI) establishes four categories of wa-
ter used in the reprocessing of medical devices, as well as the 
characteristics of each one of them, treatment methods and 
validation of treatment systems(18). Surgical instruments are 
accessories for the installation of orthopedic prostheses and 
they should not represent one more risk factor.
According to the AAMI, the characteristics associated 
with water quality that should be analyzed are: bacteria, 
endotoxins, total organic carbon, pH, hardness, dissolved 
solids, ionic contaminants, color and turbidity. Regarding 
the standard of endotoxins in purified water submitted to 
treatment by reverse osmosis or distillation, it must be <10 
UE/ml. It is noteworthy that tests must be conducted when 
the treatment system is installed, modified or repaired. 
Moreover, any alteration in the characteristics of the water 
suggests endotoxin tests. The monitoring of bacteria level 
must be performed every month, and if high levels are iden-
tified, analysis of endotoxins must be conducted(18).
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The results of the present study should be carefully re-
garded, considering that endotoxin tests are recommended 
both for devices that will be inserted and remain in the pa-
tient’s body and for the rinsing water used for reprocessing 
critical health products. There are scientists who question 
the lack of regulations and requirements of good practice of 
biomaterials manufacture, recognizing the need to perform 
regular endotoxin tests, to report values of all surfaces and to 
give special attention in the interpretation of results, since 
the minimum presence of endotoxin may cause a response 
from the immune system(3,5,19,21).
Although this is an innovative study, which used a 
methodology not yet validated, it is important to note the 
fact that the sensitivity to detect endotoxins was established 
at 0.125 UE/mL.
The fact that drinking water was used to rinse surgi-
cal instruments is considered a limitation of this study. 
However, the regulation regarding the use of purified water 
to the rinsing of critical health products was published in 
March of 2012, with a maximum period of 24 months for 
the health services to implement the required adjustments. 
The materials analyzed by this study were obtained in the 
SPD, from October to December of 2012, when the imple-
mentation project of water treatment by reverse osmosis 
was object of discussion at the hospital.
CONCLUSION
Presence of endotoxins in 13% of the sterilized ortho-
pedic surgical instruments was detected in ≥0.125 UE/
mL. The processing of surgical instruments in the SPD is 
a complex matter that involves the validation of all stages 
of the process, especially when there is possibility to pre-
vent their contamination, being necessary the adoption of 
regulations, and national and international guides for qual-
ity control.
It is worth mentioning the importance of establishing 
measures for the control of water used for processing or-
thopedic surgical instruments in the SPD. The results of 
this study suggest the difficulty of cleaning flexible bone 
reamers, therefore, further studies are required to analyze 
the impact of this finding and to recommend alternatives 
for the flexible reamers.
RESUMO
Objetivo: Investigar endotoxinas em instrumentais cirúrgicos esterilizados empregados em artroplastias do quadril. Método: Estudo 
exploratório, descritivo, desenvolvido em um hospital público de ensino. Foram selecionados seis tipos de instrumentais, a saber: raspa 
acetabular, raspa femural, saca-cabeça de fêmur, formão box, fresa de fêmur e cabeça de prova de fêmur. A seleção foi feita a partir da 
análise da dificuldade para a remoção de resíduos de sangue e osso durante a limpeza. A amostra foi constituída por 60 instrumentais 
cirúrgicos, que foram testados para endotoxinas em três momentos distintos. Foi utilizado o método de gel-clot pelo Limulus Amebócito 
Lisado (LAL) Endosafe™. Resultado: Houve formação de gel consistente com análise positiva em oito instrumentais, o que corresponde 
a 13,3%, sendo quatro raspas de fêmur e quatro fresas de fêmur. Conclusão: Foram detectadas endotoxinas em quantidade ≥0,125 
UE/mL em 13,3% dos instrumentais testados.
DESCRITORES
Endotoxinas; Instrumentos Cirúrgicos; Artroplastia de Quadril; Enfermagem Ortopédica; Enfermagem de Centro Cirúrgico.
RESUMEN
Objetivo: Investigar las endotoxinas en instrumentales quirúrgicos esterilizados empleados en artroplastias de la cadera. Método: 
Estudio exploratorio, descriptivo, desarrollado en un hospital público de enseñanza. Fueron seleccionados seis tipos de instrumentales, 
a saber: raspa de acetábulo, raspa femoral, sacacorchos (para extraer la cabeza femoral), gubia quirúrgica, fresa femoral y cabeza femoral 
de prueba. La selección se hizo desde el análisis de la dificultad para la retirada de residuos de sangre y hueso durante la limpieza. La 
muestra estuvo constituida de 60 instrumentales quirúrgicos, que fueron puestos a prueba para endotoxinas en tres momentos diferentes. 
Se utilizó el método de gelificación (Gel-clot) Lisado de Amebocitos de Limulus (LAL) Endosafe™. Resultado: Hubo formación de gel 
consistente con análisis positivo en ocho instrumentos, lo que corresponde a el 13,3%, siendo cuatro raspas femorales y cuatro fresas 
femorales. Conclusión: Fueron detectadas endotoxinas en cantidad ≥0,125 UE/mL en el 13,3% de los instrumentos probados.
DESCRIPTORES
Endotoxinas; Instrumentos Quirúrgicos; Artroplastia de Reemplazo de Cadera; Enfermería Ortopédica; Enfermería de Quirófano.
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